Loading…
Cosmos Health Inc. is projected to decline to $0.2077 by 2027, a -12% move from its current price of $0.235. COSM is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.2212 | $0.2351 | $0.2499 | +0.05% |
| Aug 6 | $0.2158 | $0.2352 | $0.2564 | +0.10% |
| Aug 7 | $0.2118 | $0.2354 | $0.2616 | +0.15% |
| Aug 8 | $0.2084 | $0.2355 | $0.266 | +0.21% |
| Aug 9 | $0.2056 | $0.2356 | $0.27 | +0.26% |
| Aug 10 | $0.203 | $0.2357 | $0.2737 | +0.31% |
| Aug 11 | $0.2007 | $0.2358 | $0.2771 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.2007 | $0.2358 | $0.2771 | +0.36% |
| Week 2 | $0.1884 | $0.2367 | $0.2974 | +0.72% |
| Week 3 | $0.1796 | $0.2375 | $0.3141 | +1.08% |
| Week 4 | $0.1726 | $0.2384 | $0.3292 | +1.45% |
| Week 5 | $0.1668 | $0.2393 | $0.3432 | +1.81% |
| Week 6 | $0.1617 | $0.2401 | $0.3565 | +2.18% |
| Week 7 | $0.1572 | $0.241 | $0.3693 | +2.55% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.
It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, Otikon ear drops, and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand.
Cosmos Health serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
Cosmos Health Inc. (COSM) trades at $0.2156 per share and has a market cap of $13.38M. It is ranked 5000 by market capitalization.
The near-term price outlook shows the 2026 forecast with a min of $0.172, an avg of $0.2156, and a max of $0.3119, with ROI 0 and sentiment NEUTRAL.
Looking further out, the forecast moves through a bearish 2030 entry (min $0.0987, avg $0.1592, max $0.2757, ROI -26.1) and then transitions to bullish in 2032-2034 (averages $0.2892, $0.2815, $0.2875 and ROIs 34.1, 30.6, 33.3). The 2040 forecast shows an average of $0.4169 (min $0.1876, max $0.9143) with ROI 93.4 and sentiment BULLISH, and by 2050 the average reaches $0.5724 with a max of $1.32, ROI 165.5, sentiment BULLISH.
A major floor 59.1% below — a decisive break under it would weaken the trend.
The nearest floor, 26.8% below — buyers have tended to step in here.
The nearest ceiling, 31.1% above — a clean break opens room to run.
A major ceiling 72.8% above — clearing it would confirm fresh momentum.
Key COSM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of COSM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.2002 | Buy | $0.2046 | Buy |
| MA 10 | $0.2053 | Buy | $0.2114 | Buy |
| MA 20 | $0.2404 | Sell | $0.2225 | Buy |
| MA 50 | $0.2348 | Buy | $0.246 | Sell |
| MA 100 | $0.2868 | Sell | $0.2977 | Sell |
| MA 200 | $0.4344 | Sell | $0.3958 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.66 | Neutral |
| Stoch RSI (14) | 36.10 | Neutral |
| CCI (20) | -45.64 | Neutral |
| Williams %R (14) | -73.39 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -22.58 | Sell |
| Bollinger %B (20,2) | 0.34 | Neutral |
| Stochastic %K (14) | 26.61 | Neutral |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 44.06 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 0.20 | Buy |
| ADX (14) | 20.40 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture shows a BEARISH sentiment, with RSI14 at 50. The SMA50 is $0.2348 and the SMA200 is $0.4344, indicating the near-term average price remains below the longer-term trend.
The 30-day range spans $0.1442 to $0.3223, underscoring a wide swing. Support is at $0.172 and resistance at $0.308, suggesting a consolidation zone around the current price. The stock exhibits an annualized volatility of 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.172 | $0.235 | $0.3401 | 0% | Neutral | |
| $0.1514 | $0.2077 | $0.3081 | -12% | Neutral | |
| $0.1431 | $0.2088 | $0.3305 | -11% | Neutral | |
| $0.1444 | $0.2221 | $0.3693 | -5% | Neutral | |
| $0.1079 | $0.1741 | $0.3014 | -26% | Bearish | |
| $0.1392 | $0.2348 | $0.4209 | 0% | Neutral | |
| $0.1788 | $0.3145 | $0.5815 | +34% | Bullish | |
| $0.1676 | $0.3071 | $0.5837 | +31% | Bullish | |
| $0.164 | $0.3126 | $0.6093 | +33% | Bullish | |
| $0.1405 | $0.2782 | $0.555 | +18% | Neutral | |
| $0.2035 | $0.4522 | $0.9917 | +92% | Bullish | |
| $0.2808 | $0.6239 | $1.44 | +166% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.172 | $0.235 | $0.3132 | +0.00% |
| September 2026 | $0.2113 | $0.2568 | $0.3256 | +9.27% |
| October 2026 | $0.1998 | $0.2463 | $0.3187 | -4.10% |
| November 2026 | $0.2006 | $0.25 | $0.3288 | +1.53% |
| December 2026 | $0.2023 | $0.2549 | $0.3401 | +1.94% |
Click any year to see its month-by-month COSM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, COSM could reach as high as $0.3401, with a base case around $0.235 and support toward $0.172 — roughly 0% from $0.235. A consolidation phase looks the most probable path here.
Expect COSM to range from $0.1514 to $0.3081 through 2027. The $0.2077 average target implies a -12% move from current prices. That is -12% versus the projected 2026 average. Price action looks broadly range-bound.
The COSM price prediction for 2028 points to an average of $0.2088 (low $0.1431, high $0.3305) — a potential decline of -11% on today's $0.235. A consolidation phase looks the most probable path here.
In 2029, COSM is projected to trade between $0.1444 and $0.3693, averaging $0.2221 — a potential decline of -5% from today's $0.235. That is up +6% on the projected 2028 average. Price action looks broadly range-bound.
Cosmos Health Inc.'s 2030 outlook centres on $0.1741, within a $0.1079 to $0.3014 range. That is -22% versus the projected 2029 average. That marks a -26% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2031, COSM could reach as high as $0.4209, with a base case around $0.2348 and support toward $0.1392 — roughly 0% from $0.235. Price action looks broadly range-bound.
Expect COSM to range from $0.1788 to $0.5815 through 2032. The $0.3145 average target implies a +34% move from current prices. That is up +34% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The COSM price prediction for 2033 points to an average of $0.3071 (low $0.1676, high $0.5837) — a potential gain of +31% on today's $0.235. Momentum favours further upside here.
In 2034, COSM is projected to trade between $0.164 and $0.6093, averaging $0.3126 — a potential gain of +33% from today's $0.235. That is up +2% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Cosmos Health Inc.'s 2035 outlook centres on $0.2782, within a $0.1405 to $0.555 range. That is -11% versus the projected 2034 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2040, COSM could reach as high as $0.9917, with a base case around $0.4522 and support toward $0.2035 — roughly +92% from $0.235. Buyers look set to stay in control over this stretch.
Expect COSM to range from $0.2808 to $1.44 through 2050. The $0.6239 average target implies a +166% move from current prices. That is up +38% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in COSM today (≈ 4,255.319149 COSM) could be worth
$2,655.06
+$1,655.06 (+166%) by 2050 · US Dollar
Based on the average projected COSM price of $0.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in COSMwould be worth at today's price.
$1,000 invested in COSM on Jul 31, 2025 (≈ 1,081.081067 COSM) would be worth
$254.05
-$745.95 (-74.6%) today · 0.25× · US Dollar
Based on a COSM entry price of $0.925 vs. today's $0.235.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.2 | $1,175 | +17.5% |
| 1 month ago | $0.202 | $1,163.37 | +16.3% |
| 3 months ago | $0.38 | $618.42 | -38.2% |
| 6 months ago | $0.46 | $510.87 | -48.9% |
| 1 year ago | $0.925 | $254.05 | -74.6% |
| All time (5.0y) ago | $5 | $47 | -95.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our COSM forecast.
Our base-case forecast reaches $0.47 around 2050.
Implied market cap at $0.47: $29.18M
The multi-year forecast points to a mixed near-term stance that gradually shifts to a more constructive longer-term outlook. In 2030, the average price is expected to be $0.1592 with a min of $0.0987 and a max of $0.2757, yielding a ROI of -26.1 and a BEARISH sentiment.
From 2032 through 2034 the forecast turns bullish, with 2032 avg $0.2892, 2033 avg $0.2815, and 2034 avg $0.2875, carrying ROIs of 34.1, 30.6, and 33.3 respectively.
The 2040 projection shows a higher average of $0.4169, a max of $0.9143, and a ROI of 93.4 with a BULLISH sentiment. By 2050, the forecast implies an average of $0.5724 and a max of $1.32, with ROI 165.5 and a BULLISH outlook. These numbers reflect a long-run potential for upside after a challenging 2030, but they are not guarantees and subject to market and company-specific risks.
Tap a question to reveal the answer.
The forecast for 2030 shows min $0.0987, avg $0.1592, max $0.2757, ROI -26.1, sentiment BEARISH.
Near term (2026) shows an average price of $0.2156 with a neutral sentiment and ROI of 0. The outlook improves in later years with bullish readings for 2032-2034 and 2040-2050, including a max forecast of $1.32 in 2050 and ROI of 165.5, but 2030 is a bear case. These are estimates, not guarantees.
The forecast maximum by 2050 is $1.32, which exceeds $1, but this is not a guaranteed outcome.
In 2040 the min is $0.1876, avg is $0.4169, and max is $0.9143, with ROI 93.4 and sentiment BULLISH.
The 30-day range is $0.1442 to $0.3223; current price is $0.2156. RSI14 is 50; SMA50 is $0.2348 and SMA200 is $0.4344. Support is $0.172 and resistance is $0.308; the 30-day outlook shows BEARISH sentiment with annualized volatility of 100%.
Cosmos Health Inc. Community Discussion
0Share your Cosmos Health Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.